Project Grant HT94252310396
Award Date 9/1/23
Completion Date 8/31/26
Dollars Obligated $673K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Piney Point, TX 77024, USA
Similar Awards
- The U.S. Department of Defense's Defense Health Agency has awarded a $1,400,000 Project Grant to The Methodist Hospital Research Institute (HMRI) in Houston, Texas under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 15, 2024 through September 14, 2027, will support the "Development of a Novel Therapeutic to Treat DNA Damage Associated with Atypical Burns". This project will focus on advanced biomedical...
- Federal Grant Award Summary The Methodist Hospital Research Institute received a $662,742 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective October 1, 2025, through September 30, 2028. This award supports a hybrid implementation-efficacy trial investigating home neuromodulation as a therapeutic intervention for neurogenic bladder management in individuals with spinal cord injury. The research will be...
- The Defense Health Agency awarded a $725,000 project grant to The University of Texas Southwestern Medical Center in Dallas, Texas, for research under the Military Medical Research and Development program. The three-year award beginning June 15, 2023, will support research into glutamine-targeted therapies to prevent traumatic heterotopic ossification. As the parent organization, the University of Texas System will provide research support services through this subaward. The Military Medical...
- The U.S. Defense Health Agency awarded a $1.2M Project Grant to HMH Hospitals Corporation (doing business as Hackensack University Medical Center) under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to investigate the mechanisms of impaired swallowing, speech, and voice in Parkinson's disease over a 3-year period from July 1, 2023 to June 30, 2026. As a not-for-profit healthcare organization, HMH Hospitals Corporation has a history of...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $746,972.00 to Texas A&M University to conduct research on "PROTECTING THE INJURED SPINAL CORD: MODULATING AUTONOMIC FUNCTION AFTER SPINAL CORD INJURY (SCI) TO REDUCE TISSUE LOSS AND IMPROVE NEUROLOGICAL OUTCOME". The research seeks to develop new treatments to improve outcomes for individuals with spinal cord injuries by investigating...
- The University of Texas Health Science Center at Houston received a $1,067,612 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for a three-year hybrid implementation-effectiveness trial examining home neuromodulation as a treatment approach for neurogenic bladder management in individuals with spinal cord injury. The award, effective October 1, 2025, through September 30, 2028, supports research and development services...
- The Defense Health Agency awarded Massachusetts General Hospital a $368,238 project grant under the Military Medical Research and Development program (CFDA 12.420) from September 1, 2023 through August 31, 2026. The grant will fund research to determine if microbiome-derived cell fragments in the brain accelerate transition from traumatic brain injury to Alzheimer's disease or related dementias. As a leading academic medical center, Massachusetts General Hospital will leverage its expertise in...
- This $444,125 federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports research by The Methodist Hospital Research Institute in Houston, TX to identify LIAX binding partners for preventing resistance. The grant aims to transform healthcare for military service members, veterans, and the broader public through innovative biomedical research. The project will run from April 1, 2025 to March 31, 2027 and focus on...
- The University of Texas Health Science Center at Houston was awarded a $1,498,514 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program. The grant will fund research from September 2022 through September 2026 to improve functional performance in transfemoral amputees through somatosensory augmentation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...